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Abstract
Background: Ehrlichia chaffeensis is a tick-transmitted rickettsial pathogen responsible for an important emerging
disease, human monocytic ehrlichiosis. To date how E. chaffeensis and many related tick-borne rickettsial
pathogens adapt and persist in vertebrate and tick hosts remain largely unknown. In recent studies, we
demonstrated significant host-specific differences in protein expression in E. chaffeensis originating from its tick and
vertebrate host cells. The adaptive response of the pathogen to different host environments entails switch of gene
expression regulated at the level of transcription, possibly by altering RNA polymerase activity.
Results: In an effort to understand the molecular basis of pathogen gene expression differences, we isolated
native E. chaffeensis RNA polymerase using a heparin-agarose purification method and developed an in vitro
transcription system to map promoter regions of two differentially expressed genes of the p28 outer membrane
protein locus, p28-Omp14 and p28-Omp19. We also prepared a recombinant protein of E. chaffeensis s70
homologue and used it for in vitro promoter analysis studies. The possible role of one or more proteins presents in
E. chaffeensis lysates in binding to the promoter segments and on the modulation of in vitro transcription was also
assessed.
Conclusions: Our experiments demonstrated that both the native and recombinant proteins are functional and
have similar enzyme properties in driving the transcription from E. chaffeensis promoters. This is the first report of
the functional characterization of E. chaffeensis RNA polymerase and in vitro mapping of the pathogen promoters
using the enzyme. This study marks the beginning to broadly characterize the mechanisms controlling the
transcription by Anaplasmataceae pathogens.
Background
Ehrlichia chaffeensis is an obligate intracellular rickett-
sial pathogen and the causative agent of an important
emerging zoonotic disease, human monocytic ehrlichio-
sis [1-4]. This Amblyomma americanum tick-trans-
mitted pathogen causes infections in susceptible hosts
(humans), host reservoirs (white-tailed deer), and less
well described hosts such as the dog, goat and coyote
[5-10]. E. chaffeensis has an unusual developmental
cycle that requires growth and replication within
eukaryotic cells of vertebrate and tick hosts [11]. During
its developmental cycle, there is conversion between two
distinct morphological forms, the elementary bodies
(EBs) and reticulate bodies (RBs) [12,13]. The EBs are
the infectious form and upon entry into a host cell, they
differentiate into metabolically active reticulate bodies
(RBs), which are larger compared to EBs and divide by
binary fission [12-14]. The reticulate bodies are also
non-infectious forms [14]. Later in the developmental
cycle, RBs convert back to EBs, which are released from
infected cells [12,14]. The transformation of RBs to EBs
by E. chaffeensis is observed in both vertebrate and tick
hosts [15]. * Correspondence: rganta@vet.k-state.edu
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dual hosts by adapting to changes in different host
environments is unclear. Recent studies described the
differential gene and protein expression profiles of the
pathogen originating from tick and mammalian cell
environments [15-18]. Moreover, E. chaffeensis organ-
isms recovered from infected tick cells produce longer-
lasting infections in mice compared to the infection
with organisms harvested from mammalian macro-
phages [19]. Differentially expressed proteins of E. chaf-
feensis included the predominant expression from outer
membrane protein genes p28-Omp19 and p28-Omp14
in mammalian and tick cell environments, respectively
[15-19]. The adaptive response to different host environ-
ments requires altering the gene expression, often regu-
lated at the transcriptional level by altering RNA
polymerase (RNAP) activity [20]. A typical bacterial
RNAP consists of five polypeptide chains; two a subu-
nits, one each of b and b’ subunits, and a s subunit.
The enzyme can take two forms, a holoenzyme contain-
ing all four different subunits or core polymerase that
lacks a s subunit [21]. The capacity to synthesize RNA
resides in the core polymerase and the role of a s subu-
nit is to direct initiation of transcription from specific
promoters [22,23]. The genome of E. chaffeensis
includes two sigma factor genes; the homologs of the
major bacterial sigma factor, s
70, and an alternative
sigma factor, s
32 [24]. The current lack of established
methods to stably transform, transfect, conjugate, or
electroporate E. chaffeensis remain a major limiting fac-
tor to study mechanisms of gene expression by tradi-
tional methods. Mapping the functions of E. chaffeensis
genes in vivo cannot be performed because genetic
manipulation systems are yet to be established. To over-
come this limitation, in a recent study we reported the
utility of Escherichia coli RNAP as a surrogate enzyme
to characterize E. chaffeensis gene promoters [25].
Although the E. coli RNAP proved valuable for mapping
E. chaffeensis gene promoters, the extrapolation of the
data requires further validation using the E. chaffeensis
RNAP.
In this study, we developed a functional in vitro tran-
scription system by utilizing G-less transcription tem-
plates [26] to drive transcription from two E. chaffeensis
promoters. We described the partial purification and
characterization of E. chaffeensis RNAP and its use in
characterizing the transcriptional profiles of two p28-
Omp gene (p28-Omp) promoters. In this study, we also
described the recombinantly expressed E. chaffeensis
sigma factor, s
70, and its use in promoter analysis stu-
dies after its reconstitution with E. coli core enzyme.
Modulatory effect of E. chaffeensis protein lysates on in
vitro transcription is also described in this study to
serve as the first step towards determining the
regulatory mechanisms underlying gene expression in
this pathogen.
Results
Isolation of E. chaffeensis RNA polymerase (E. chaffeensis
RNAP)
E. chaffeensis DNA-dependent RNA polymerase (E.
chaffeensis RNAP) was partially purified from the organ-
isms grown in macrophage cultures by adapting
heparin-agarose column purification method described
earlier for other bacterial systems [27]. To determine
the purity and polypeptide composition of the E. chaf-
feensis RNAP, several eluted fractions were electrophor-
esed on a polyacrylamide gel that was stained using
silver nitrate (Figure 1A). The gel pattern revealed that
the E. chaffeensis RNAP had a subunit structure similar
to E. coli RNAP (that is also typical of other eubacteria)
with five major subunits (a2, b, b’, s). Western blot ana-
lysis confirmed the presence of E. chaffeensis s
70 poly-
peptide when assessed using a heterologous E. coli anti-
s
70 monoclonal antibody, 2G10 (Figure 1B). Amino acid
alignment of the sequence of E. chaffeensis s
70 polypep-
tide with E. coli s
70 polypeptide revealed significant
homology which also spanned to the putative binding
site sequence of 2G10 antibody to E. coli s
70 polypep-
tide [28,29] (Figure 2). The homology between amino
acid residues of s
70 polypeptides recognised by 2G10
antibody [28] is considerably higher between E. chaffeen-
sis and E. coli than between E. chaffeensis and Chlamy-
dia trachomatis . Protein BLAST search (at National
Center for Biotechnology Information Bethesda, MD,
USA) of the putative amino acid binding site sequence
of 2G10 in E. coli [28,29] against E. chaffeensis (Arkan-
sas isolate) genome identified only one significant match
(E-value of 1e
-11 and having 69% identity) with E. chaf-
feensis RNAP s
70 polypeptide, RpoD.
In support of testing the functionality of p28-Omp14
and p28-Omp19 gene promoters, we constructed in
vitro transcription templates, pRG147 and pRG198, by
cloning the promoter regions of the genes into the
pMT504 plasmid (Figure 3). The plasmid pMT504 is a
G-less cassette containing two transcription templates
cloned in opposite directions to aid in driving transcrip-
tion from promoters introduced upstream of the G-less
cassette sequences [26]. (The promoter segments were
amplified from E. chaffeensis genomic DNA using the
primers listed in Table 1.) The functionality of the pro-
moters of p28-Omp14 and p28-Omp19 in correct orien-
tation, in plasmids pRG147 and pRG198, was initially
confirmed using E. coli holoenzyme containing its s
70
polypeptide (Figure 4). Subsequently, transcriptional
activity of the heparin-agarose purified RNAP fractions
was evaluated. E. chaffeensis RNAP activity was detected
in purified pooled fractions (data shown for pRG198 in
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i nt h ep r e s e n c eo fa n t i - s
70 monoclonal antibody, 2G10,
or in the presence of rifampicin (Figure 4). Further char-
acterization using varying salt concentrations showed
that the enzyme was active in presence of potassium
acetate up to 200 mM concentration and was inhibited
at 400 mM (Figure 5A), and the optimum concentration
for activity of the enzyme for sodium chloride was
observed at 80 mM (Figure 5B).
In vitro transcription by recombinant E. chaffeensis-s
70
We reconstituted E. coli RNAP core enzyme with
recombinantly expressed E. chaffeensis s
70 and the
resulting holoenzyme effectively transcribed the promo-
ters of p28-Omp14 and p29-Omp19 (data presented for
p28-Omp 19 promoter in Figure 6), but the core enzyme
alone or recombinant E. chaffeensis s
70 alone did not
drive the transcription. Saturation of the purified
enzyme with recombinant s
70 also resulted in enhanced
transcriptional signals (Figure 6). General transcriptional
profile of both the reconstituted enzymes in the pre-
sence of varying potassium acetate concentrations were
similar (Figure 7), although a relatively stronger tran-
scriptional signal at 400 mM salt concentration was
detected for E. coli core enzyme saturated with E. chaf-
feensis recombinant s
70 subunit (Figure 7).
Modulation of E. chaffeensis RNAP activity by whole-cell
protein
We evaluated the effect of E. chaffeensis whole-cell pro-
tein lysate, prepared from the bacteria grown in macro-
phage cell line, on transcription of p28-Omp14 and p28-
Omp19 constructs using the native purified enzyme.
T h er e s u l t i n gt r a n s c r i p t sw e r ea n a l y z e db yt w o
independent methods; densitometry of radiolabeled
transcripts and the Taq-Man probe-based, real-time RT-
PCR. These analyses showed enhanced transcriptional
activity in the presence of 4 μgo fE. chaffeensis whole-
cell lysate. Densitometric analysis revealed a 1.8-fold
increase in transcriptional signal for the p28-Omp14
promoter construct and a 2.1-fold increase for p28-
Omp19 construct (Table 2). Addition of the same
amount of protein yielded a similar fold increases when
transcription was assessed with E. coli core enzyme satu-
rated with E. chaffeensis recombinant s
70. No transcrip-
tion occurred with the addition of whole-cell lysate
alone in the absence of an enzyme, a potential source of
E. chaffeensis RNAP. Similarly, the addition of boiled
lysate did not cause any change in transcriptional sig-
nals. Quantitation by real-time RT-PCR for the calcula-
tion of fold increase in transcription in the presence of
E. chaffeensis whole-cell protein lysate was carried out
as described previously [30,31]. Transcription of p28-
Omp19 construct with purified E. chaffeensis RNAP, as
quantified by real-time RT-PCR, showed a 2.24 fold
enhancement in the presence of 4 μgo ft h ep r o t e i n
lysate, whereas transcription of p28-Omp14 promoter
construct resulted in a 1.81 fold-enhancement (Table 2),
indicating a higher degree of agreement between the
data generated by densitometric and real-time RT-PCR
methods of quantitation (Table 2).
EMSA analysis of upstream sequences of p28-Omp14 and
p28-Omp19 promoters
Electrophoretic mobility shift assay (EMSA) experiments
utilizing the complete promoter regions of the p28-
Omp14 and p28-Omp19 of E. chaffeensis showed pro-
moter-specific binding of tick cell- or macrophage-
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Figure 1 E. chaffeensis RNA polymerase purification by employing heparin agarose column purification method. A) Silver-stained SDS-
PAGE gel profile of heparin agarose purified fractions of E. chaffeensis RNA polymerase. M, protein standards (kDa); C, E. chaffeensis crude lysate;
W1, first wash fraction from the column; W2, second column wash; E1, first elution fraction; E2, second elution fraction; P, pooled dialyzed
fractions of eluted fractions 3 to 6; Ec, E. coli holoenzyme from Epicenter
® B) Western blot analysis of the proteins resolved in panel A with E.
coli anti-sigma70 monoclonal antibody, 2G10.
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Page 3 of 15ECH    ----------MKDLQTDKEL--LRTLVSKGLKQGFVTFNDINDVFSDYVLSSDNIDETIS 48 
ECOLI  ----------ME--QNPQSQ--LKLLVTRGKEQGYLTYAEVNDHLPEDIVDSDQIEDIIQ 46 
CTR    MRMDTLDSQAAEAAQEEEIQRKLEELVTLAKDQGFITYEEINEILPPSFDTPEQIDQVLI 60 
                  :  *  :    *. **: . .**::*: ::*: :.  .  .::*:: :  
 
ECH    MLQDSGINVLEQSDEDEANSIIEENRIKDEMDEDDVSDTSIKSWDFGQTDDPIRMYLCEM 108
ECOLI  MINDMGIQVMEEAP-DADDLMLAENTADEDAAEAAAQVLSSVESEIGRTTDPVRMYMREM 105
CTR    FLAGMDVQVLNQADVERQKERKKEAKELEGLAKRSE----------GTPDDPVRMYLKEM 110
       :: . .::*::::  :  .    *    :   :             * . **:***: ** 
 
ECH    SSVELLSREGEIEIAKKIKSEKVNMLRSLVESPIVLRTFMSWRDDLVNEQIMLRDLIDLD 168
ECOLI  GTVELLTREGEIDIAKRIEDGINQVQCSVAEYPEAITYLLEQYDRVEAEEARLSDLITGF 165
CTR    GTVPLLTREEEVEISKRIEKAQVQIERIILRFRYSTKEAMSIAQYLINGKERFDKIVS-- 168
       .:* **:** *::*:*:*:.   ::   : .        :.  : :   :  : .::    
 
ECH    ANYRYEFPEKFSDTDDASVLGYDKDLMDEPDEDP-DIPEDEDEENISINASILEMENALL 227
ECOLI  VDPNAEEDLAPTATHVGSELS-QEDLDDDEDEDEEDGDDDSADDDNSIDPELAREKFAEL 224
CTR    ------EKEVEDKTHFLNLLP--------------------------KLISLLKEEDAYL 196
                    *.  . *                              .: . : * * 
 
ECH    -PKVVSILDSVIAS-------AEKILELKKQYQGKINQDIEKQYNDLHDSIWEMIYQIKL 279
ECOLI  RAQYVVTRDTIKAKGRSHATAQEEILKLSEVFK--QFRLVPKQFDYLVNSMRVMMDRVRT 282
CTR    EERLLALKDPALSK-----PDQARLNDELEKCR-IRTQAYLRCFHCRHNVTEDFGEVVFK 250
         : :   *.  :.         .: .  :  :    :   : :.   :    :   :   
 
ECH    SNSAVLSITQQIYSLSKSIAAEEAKIISLAESYGIQRKDFLDAYNTNSVLQKKGTSPQWD 339
ECOLI  QERLIMKLCVEQCKMPK------KNFITLFTGN-----ETSDTWFNAAIAMNK----PWS 327
CTR    AYDSFLQLEQQINDLKAR-----------------------------------------A 269
           .:.:  :  .:                                              
 
ECH    NMLLNEESNIVSMYSKIKLLSGEN--NLTEFKALVTKIQKHERAANQAKQEMIKANLRLV 397
ECOLI  EKLHDVSEEVHRALQKLQQIEEETGLTIEQVKDINRRMSIGEAKARRAKKEMVEANLRLV 387
CTR    ERNKFAAAKLAAARRKLHKREVAAGRTLEEFKKDVRMLQRWMDKSQEAKKEMVESNLRLV 329
       :       ::     *::  .     .: :.*     :.     :..**:**:::***** 
 
ECH    VSIAKKYSNRGLQFLDLVQEGNIGLMKAVDKFDYKRGYKFSTYATWWVRQAITRAIADQA 457
ECOLI  ISIAKKYTNRGLQFLDLIQEGNIGLMKAVDKFEYRRGYKFSTYATWWIRQAITRSIADQA 447
CTR    ISIAKKYTNRGLSFLDLIQEGNMGLMKAVEKFEYRRGYKFSTYATWWIRQAVTRAIADQA 389
       :******:****.****:****:******:**:*:************:***:**:***** 
 
ECH    RTIRIPVHMIETVNKINRTLRQMLHEMGREPTLEELSARLNINVDKIRKVMKIVKDPVSL 517
ECOLI  RTIRIPVHMIETINKLNRISRQMLQEMGREPTPEELAERMLMPEDKIRKVLKIAKEPISM 507
CTR    RTIRIPVHMIETINKVLRGAKKLMMETGKEPTPEELGEELGFTPDRVREIYKIAQHPISL 449
       ************:**: *  :::: * *:*** ***. .: :  *::*:: **.:.*:*: 
 
ECH    ESPIGDDDSSTFGDCIEDKRAVKPEDAAVLADLREITTKVLSTLTPKEERILRMRFGIGK 577
ECOLI  ETPIGDDEDSHLGDFIEDTTLELPLDSATTESLRAATHDVLAGLTAREAKVLRMRFGIDM 567
CTR    QAEVGDGGESSFGDFLEDTAVESPAEATGYSMLKDKMKEVLKTLTDRERFVLIHRFGLLD 509
       :: :**. .* :** :**.    * :::    *:    .**  ** :*  :*  ***:   
 
ECH    GGKDHTLEEVGKLFNVTRERIRQIEAKALRKLRHPSRARKLRGFF--------------- 622
ECOLI  N-TDYTLEEVGKQFDVTRERIRQIEAKALRKLRHPSRSEVLRSFLDD------------- 613
CTR    G-RPKTLEEVGSAFNVTRERIRQIEAKALRKMRHPIRSKQLRAFLDLLEEEKIGSGKIKS 568
       .    ******. *:****************:*** *:. **.*:                
 
ECH    --- 
ECOLI  --- 
CTR    YKN 571 
Figure 2 Comparative alignment of complete amino acid sequences of E. chaffeensis (ECH), E. coli (ECOLI) and C. trachomatis (CTR)
major s subunit to show sequence homology. The GenBank accession numbers for these sequences are NC007799, NC000913 and
NC012687, respectively. The numbers of the amino acids of the corresponding genus are indicated at the far right. Asterisks denote amino acid
homology; dots denote amino acid mismatch. Dashes are gaps introduced into the sequence to improve the alignment. The shaded amino acid
sequence represents the putative binding site of the E. coli anti-s
70 monoclonal antibody, 2G10 [29].
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Page 4 of 15derived E. chaffeensis proteins (not shown). Addition of
50 ng of specific competitor DNAs consisting of unla-
beled full length promoter DNA of p28-Omp14 or p28-
Omp19 abolished the shift of DNA-protein complex
migration for both promoter regions. To further assess
the interactions of Ehrlichia proteins with putative
upstream sequences, five biotin-labelled short upstream
DNA segments of p28-Omp14 (probes P1 to P5) (Figure
8A) and two DNA segments of p28-Omp19 (P6 and P7)
(Figure 8B) promoters were prepared and used in the
EMSA experiments. The promoter sequences of genes
14 and 19 included direct repeats and palindromic
sequences [25]. The probes included one or more of the
sequences. Three of the five probes for the p28-Omp14
promoter region exhibited significant shift in mobility in
the presence of protein lysate from macrophage derived
E. chaffeensis compared to the controls which contained
probe alone with no lysate added or when non-specific
protein was added to the probe fragments (Figure 9A).
A shift in mobility was also noted in the interaction
with one probe segment of the p28-Omp19 promoter
region when the protein lysate was added (Figure 9B).
Addition of a 50-fold excess of unlabeled specific-com-
petitors in the binding reactions significantly reduced
the mobility shift of the probes. Densitometry analysis
of the mobility shifted fragments differed for each probe
compared to the non-shifted fragments. The P1 probe
had 84% shift which reduced to 29% when competitor
DNA was added; P2 and P3 probes had about 31%, and
27% shifts, respectively, and the shifts for these probes
were completely abolished in the presence of specific
competitors. The p28-Omp19 promoter region probe
had about 23% shift which was reduced to 10% in the
presence of specific competitor.
Discussion
A major impediment to the study of regulation of gene
expression in the human monocytic ehrlichiosis patho-
gen, E. chaffeensis, is the absence of an experimental
genetic manipulation system due to the inability to sta-
bly transform the organism. To partially overcome this
constraint, we constructed plasmid transcription tem-
plates by transcriptional fusion of p28-Omp14 and p28-
Omp19 promoters to a G-less transcriptional template
and isolated E. chaffeensis RNAP to create a system for
transcriptional analysis in vitro, similar to studies
reported for Chlamydia species [20,26,32-35]. We
adapted the bacterial RNAP purification methods
reported in the literature [21,27,36,37] to recover func-
tionally active E. chaffeensis RNAP. The procedure has
been modified from a single-column purification
method used for RNAP from E. coli, Bacillus subtilis,
Chlamydia trachomatis, Rickettsia prowazekii and to
recover the enzymes from several other bacterial organ-
isms [21,27,37]. The purification steps involved the use
of sodium deoxycholate, a bile salt often used in cell
lysis but reportedly effective in the isolation of mem-
brane proteins and in affinity chromatography by
pMT504
3352 bp
G-less test transcript
G-less control transcript
AmpR
16S rDNA promoter
EcoRV (48)
pRG147
3906 bp
p28-Omp14 promoter
pRG198
3659 bp
p28-Omp19promoter
Figure 3 Construction of transcription plasmids, pRG147and pRG198. The plasmids were constructed by cloning PCR-amplified E.
chaffeensis-specific promoters of p28-Omp14 (pRG147) and p28-Omp19 (pRG198) into the EcoRV located upstream of a G-less cassette in pMT504
[26].
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Primers/probes Sequence
1Orientation Reference
For cloning p28-Omp14 and p28-Omp19 promoters into pMT504
RRG217 (p28-Omp14) 5"-ttgctcaaccataaaataatggga F 25
RRG695 (p28-Omp14) 5"-taaaaatttaagaataatgaaag R This study
RRG185 (p28-Omp19)*
# 5"-GACTCTAGActtttaattttattattgccacatg F 25
RRG696 (p28-Omp19) 5"-aaataaattaacaatagtagaag R This study
For cloning RpoD gene into pET32
RRG742* 5"-GAGCCATGGcttaacaaattctatattttccctaactc F This study
RRG743* 5"-CGCTCGAGttaactattgatattacaatgacctagt R This study
For TaqMan RT-PCR of test G-less transcripts
RRG766 5"-ccttcctccatctataccac F This study
RRG767 5"-gagagtgaatgatgatagatttg R This study
RRG765 (TaqMan Probe) 5"-cattattcctcctatcttctcctcttctc This study
For TaqMan RT-PCR of control G-less transcripts
RRG769 5"-tactcacccaatactcccta F This study
RRG770 5"-gtggaatgagaaatgagtgt R This study
RRG768 (TaqMan Probe) 5"-cttatcctctcctcacctctccctc This study
For sequencing pRG198
M13F-40 5"-gttttcccagtcacgac Commercial
p28-Omp14 promoter EMSA probes
Full length probe
RRG 217** F
RRG 218 5’ gttaataaaccttttataaaag R 25
Probe 1 (P1)
RRG217** F
RRG623 5"-ggtttagccattttaaatgtg R This study
Probe 2 (P2)
RRG267 5"-cagttaactttctgtaaacttc F 25
RRG623 5"-ggtttagccattttaaatgtg R This study
Probe 3 (P3)
RRG269 5"-cgttttctgctttattagaatg F 25
RRG625 5"-gtacatgcattatgagcaaatc R This study
Probe 4 (P4)
RRG270 5"-gttccgtatttattaatatatg F 25
RRG626 5"-ctatacttaactttactactta R This study
Probe 5 (P5)
RRG272 5"-ggataagtactttagcaagtgg F 25
RRG627 5"-gtctagaatataaaatttctttc R This study
p28-Omp19 promoter EMSA probes
Full length probe
RRG 185** F2 5
RRG 445 5’ atataacctaatagtgacaaataaattaac R This study
Probe 6 (P6)
RRG185** F2 5
RRG628 5"-gcacttataaactagtccc R This study
Probe 7 (P7)
RRG276 5"-gtgctgtttttctcacctttacac F 25
RRG629 5"-cttttgtaaggaaaatttaatata R This study
1F, forward primer; R, reverse primer
* Text in capital letters refers to sequences inserted for creating restriction enzyme sites
#Text in bold and italics letters refers to 7 nucleotides of coding sequence from the 3” end of p28-Omp18 gene used in the primer
** Primer sequences were presented only once when a primer was described for the first time.
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be critical for the recovery of active enzyme, since pre-
vious studies in R. prowazekii, a closely related species,
showed that up to 62% of total RNAP activity was asso-
ciated with membrane proteins [27]. The heparin-agar-
ose purification step is known to remove RNAP
inhibitors and endogenous DNA [27]. The recovered
E. chaffeensis enzyme showed transcriptional activity for
both p28-Omp14 and p28-Omp19 promoters and
marked the first study describing RNAP activity of
E. chaffeensis. SDS-PAGE profile suggested that the
enzyme is partially pure and E. chaffeensis RNAP has a
typical bacterial holoenzyme composition with five
major subunits, a2, b, b’, and s.
The enhanced RNAP activity following addition of
E. chaffeensis recombinant sigma 70 suggests that the
preparation had less than stoichiometric amounts of the
sigma factor, which is consistent with findings of the
recovery of E. coli RNAP when employing similar proce-
dures [22,27]. Previous studies suggest that RNAPs puri-
fied by heparin-agarose chromatography methods are
only about 30% saturated with the major sigma factor,
s
70 [21] and do not co-purify with alternative sigma fac-
tors, such as a s
32 homolog [20].
In this study, we presented evidence that the major
E. chaffeensis sigma subunit, s
70, was also recognized by
a heterologous E. coli anti-s
70 monoclonal antibody,
2G10. Functional studies with the 2G10 suggest that
this antibody can effectively inhibit in vitro transcrip-
tional activity of E. coli [29] and C. trachomatis RNAP
holoenzymes [28]. Similarly, this antibody inhibited the
E. chaffeensis RNAP activity. These data are consistent
with our bioinformatic analysis that the putative 2G10
antibody binding site sequences of E. coli and E. chaf-
feensis s
70 subunits of RNAP share high degree of
homology. Transcriptional inhibition of the enzyme by
the anti- s
70monoclonal antibody and rifampin, a potent
inhibitor of prokaryotic RNAP [27,38], demonstrates
that the in vitro transcriptional activity in our study was
due to the isolated E. chaffeensis RNAP.
Transcriptional profiles depicting salt tolerance of pur-
ified enzymes have been described for prokaryotes, such
as, C. trachomatis and E. coli [20,39]. In E. coli,t r a n -
scription of a s
70-regulated promoter decreases dramati-
cally between 100 mM and 150 mM potassium acetate
[39], whereas s
66-dependent promoter activity of Chla-
mydia is completely inhibited at 400 mM concentration
[20]. The purified E. chaffeensis RNAP, reported in this
study, also showed a similar range of salt tolerance as
observed for other bacterial s
70 dependent RNAPs. For
example, the enzyme showed optimum transcriptional
activity at 80 mM sodium chloride, a slight difference
from the optimal 50 mM concentration reported for the
R. prowazekii RNAP [27]. The minor differences in the
salt tolerance properties may be unique to E. chaffeensis
RNAP.
Previous studies suggest that RNAP fractions purified
by heparin-agarose chromatography methods are typi-
cally about 30% saturated with the major sigma subunit
[20]. Thus the presence of free core enzymes in the pre-
paration allows reconstitution studies or saturation with
recombinant sigma factors to enhance transcription
in vitro. Thus we prepared a purified recombinant E.
chaffeensis s
70 subunit and used for assessing transcrip-
tional activity by saturation of the native enzyme or by
reconstitution with E. coli core enzyme. Saturation of
the purified RNAP with the recombinant subunit
resulted in enhanced transcriptional signals. Reconstitu-
tion of E. coli core enzyme with E. chaffeensis recombi-
nant s
70 subunit had similar salt sensitivities to that of
purified E. chaffeensis RNAP before and after saturating
with the recombinant subunit. These data are consistent
with earlier reports indicating that purified C. psittacci
s
66 was effective in stimulating transcription by C. tra-
chomatis and C. psittaci RNAP preparations [32] and
highlights that E. coli core enzyme reconstituted with
E. chaffeensis sigma factor offers an alternative approach
to in vitro characterization of E. chaffeensis promoters
as described for C. trachomatis [20,33]. Previously, we
and others reported the use of E. coli system in charac-
terizing the promoters of E. chaffeensis [25,40]. The cur-
rent study offers an additional advantage over the E. coli
system in that it uses E. chaffeensis RNAP or E. coli
core enzyme with E. chaffeensis recombinant s
70.
Regulation of gene transcription in prokaryotes
involves a complex network and is controlled at the
stage of RNA synthesis in which transcription factors
(TFs) are key components [41,42]. TFs play an impor-
tant role in regulating the transcription of specific genes
by acting on the DNA regulatory sequences within the
gene promoters [41,42]. When a transcription factor
binds to a specific promoter, it can either activate or
repress transcription [35,43,44]. To investigate the possi-
ble modulatory role of E. chaffeensis proteins on tran-
scription of promoters of two differentially expressed
genes, p28-Omp14 and p28-Omp19, we prepared E.
chaffeensis whole-cell protein lysate from macrophage-
derived bacteria and evaluated its effect on transcription
in vitro. Addition of the macrophage cell infection-
derived E. chaffeensis protein extracts resulted in
enhanced transcription suggesting that promoters of the
p28-Omp14 and p28-Omp19 genes may be regulated in
response to changing environments of the pathogen.
Importantly, the enhanced in vitro transcription
observed in this study in response to addition of protein
extracts suggests that the lysates contain transcription
regulators. Given the differential expression of p28-
Omp14 and p28-Omp19 genes [15] in vertebrate and
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Page 7 of 15invertebrate hosts, the hypothesis that promoters of
these genes may be under both positive and negative
regulation in response to the changing host environ-
m e n t si sa l s op l a u s i b l e .T h i sh y p o t h e s i sr e q u i r e sa d d i -
tional investigations, including the evaluation of the
impact of tick cell environment. As an organism may
express diverse array of transcription factors, it is highly
likely that E. chaffeensis may regulate its gene expression
via modulating the expression of transcription factors in
support of maintaining its existence in dual hosts. Tran-
scription regulation of a gene is a dynamic process and
is responsive to environmental cues under which TFs
162
125
Transcript size
(nucleotides)
G   A   T   C        1        2        3       4         5         6       7        Ab Rf
Figure 4 Transcriptional analysis of E. coli and E. chaffeensis RNAPs using p28-Omp 14 and 19 promoters. Transcription of pRG147 (lane
1), pRG147R (lane 2), pRG198 (lane 3), pRG198R (lane 4), pMT504 (lane 5) was assessed using E. coli holoenzyme or with E. coli core enzyme with
pRG198 (lane 6). Transcription of pRG198 by HA-purified E. chaffeensis RNAP (lane 7); inhibition of transcription of E. chaffeensis RNAP by the
addition of 4 μg of 2G10 (Ab); inhibition of transcription of E. chaffeensis RNAP by addition of 25 μg/ml of rifampin (Rf). Inhibition assays were
performed using pRG198. GATC, sequencing ladder generated using the plasmid pRG198 sequenced with primer M13F-40 to serve as the
molecular weight markers.
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Figure 5 In vitro transcription showing the effect of varying
salt concentrations of potassium acetate (Panel A), and sodium
chloride (panel B). Transcription of the p28-Omp19 promoter
region in pRG198 plasmid was assessed using the purified E.
chaffeensis RNAP.
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Figure 6 Transcriptional analysis of recombinant E. chaffeensis-
s
70 using pRG198 transcriptional template. C, transcription
products by E. coli core enzyme alone; s
70, transcription products
by the recombinant E. chaffeensis s
70 protein; N, transcription
products by purified E. chaffeensis RNAP; C + s
70, transcription
products by by E. coli core enzyme saturated with recombinant E.
chaffeensis s
70;N+s
70, transcription products by native purified
enzyme saturated with recombinant E. chaffeensis-s
70.
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Page 8 of 15trigger regulation [39,45-47]. This study shows the first
evidence of stimulatory effect of E. chaffeensis whole-cell
protein extract on the transcription of both p28-Omp14
and p28-Omp19 promoters in vitro. In our previous stu-
dies, we reported that the expression levels of the p28-
Omp14 and p28-Omp19 genes are different in macro-
phage and tick cell environments [16,19]. Although both
the genes are transcriptionally active in macrophage
host cell environment under in vitro and in vivo condi-
tions, the expression levels for p28-Omp19 is higher for
the bacteria in infected macrophages, whereas in tick
cells p28-Omp14 is the predominantly expressed protein
[16,19]. Consistent with those observations, the promo-
ter constructs of both p28-Omp14 and p28-Omp19
genes remained active and enhanced when E. chaffeensis
protein lysates prepared from macrophage culture
derived organisms were added. Additional investigations
are needed to further define the differences in the
expression levels for the p28-Omp14 and p28-Omp19
genes in macrophage and tick cell environments. A gene
in a cell may be regulated by different TFs, and the con-
tribution from different TFs may be variable under dif-
ferent environmental conditions [48]. Thus, more
detailed investigations are needed to map quantitative
differences in the transcription and to further assess the
complex regulatory network of transcription in E.
chaffeensis.
The current study provides the first evidence suggest-
ing that E. chaffeensis whole-cell protein lysates contain
regulatory proteins which modulate transcription of
p28-Omp14 and p28-Omp19 promoters in vitro.I ns u p -
port of further testing the hypothesis that E. chaffeensis
whole-cell protein lysates contain proteins that bind to
putative regulatory DNA sequences of these promoters,
EMSA experiments were performed. A shift in mobility
of DNA fragments was observed for several partial or
complete DNA segments of the promoter regions of
both p28-Omp14 and p28-Omp19 genes. These data
suggest that the promoter region contained regulatory
DNA sequences that allowed binding of one or more E.
chaffeensis proteins. The binding was specific as the
addition of specific competitors considerably reduced
the shift and the addition of a non-specific protein did
not cause a shift. The binding of E. chaffeensis regula-
tory proteins to the DNA segments spanning putative
DNA binding elements is consistent with previous stu-
dies on this organism [49] as well as in several other
bacteria, including Anaplasma phagocytophilum [50-52],
C. trachomatis [34,35]and B. subtilis [53,54]in which
interaction of regulatory proteins with regulatory
sequences have been demonstrated. The identity of
DNA binding proteins and the location of protein bind-
ing sites remain to be determined.
Conclusions
In this study, we developed in vitro transcription assays
using a G-less cassette and described methods to isolate
native RNAP and the recombinant RNAP s70 subunit
of E. chaffeensis. The value of using these tools in evalu-
ating the promoters of two differentially expressed genes
has been demonstrated. The application of these tools
to the study of E. chaffeensis is new and important for
furthering our understanding of the regulation of gene
expression in this pathogen. Specifically, the tools will
be valuable in studies to map specific interactions of E.
chaffeensis proteins in driving differential gene
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Figure 7 Transcription of pRG198 with varying potassium
acetate concentrations showing transcription by E. chaffeensis
RNAP saturated with the recombinant s
70 and by E. coli core
RNAP reconstituted with recombinant s
70.
Table 2 Effect of macrophage-culture grown E. chaffeensis whole-cell lysate on the transcription of p28-Omp14
(pRG147) and p28-Omp19 (pRG198) promoter constructs quantitated by densitometry and real-time RT-PCR (fold
change)
Densitometry
# Real-time RT-PCR
Template no lysate
(x ± std)
with lysate
(x ± std)
fold increase p-value* no lysate
(Ct ± std)
with lysate
(Ct ± std)
fold increase p-value*
pRG147 83.3 ± 1.8 45.5 ± 1.9 1.8 <0.0001 17.51 ± 0.81 16.64 ± 0.23 1.81 0.0174
pRG198 76.9 ± 1.7 35.7 ± 1.6 2.2 <0.0001 17.48 ± 0.08 16.27 ± 0.06 2.24 0.0013
#volume of the unoccupied space available under the signal is quantitated
*p-value of ≤ 0.05 is significant
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Page 9 of 15ttgctcaacccataaaataatgggaaattaccttttctaggaagtttctcattatttaacagttaactttctgtaaacttctaataa
cagtattttgttcactcttccccttaataaaaatcataagtttacaataatgtcaaaaagatttctttttaaacacatttaaaatgg
ctaaaccgttttctgctttattagaatgattcccaaataaattttaattaattactgttccgtatttattaatatatgttataatgt 
aattaaataaggatactagatttgctcataatgcatgtactgaatttgtgatttgaaataacaagacttaaatgtcgaatttagctt
ctgtcctagtggataagtactttagcaagtggtaaaagcaagtctactcatatttttattaattaagtagtaaagttaactatagat
tttattaaaatttttattctaatcactttaaatatcaattacttttgttgtaaatttgaaagaaattttatattctagacTTGCTTt
tctttatttctttcatTATTCTtaaatttttattatcttttataaaaggtttattaac
-35
-10 RBS *
P1
P2
P3
P4
P5
ttttattattgccacatgttaaaaataatctaaacttgtttttattattgctgcaggtaaataaaaatagtggcaaaagaatgtagc
aataagaggggggggggggggactagtttataagtgctgtttttctcacctttacacatgatactatacttaaccagtttttttgct
attacttacctgacgtaatatattaaattttccttacaaaagttaccgatattttatacaaaaatttatattctgacTTGCTTttat
atgacacttctacTATTGTtaatttatttgtcactattaggttatat
-35
-10
P6
P7
RBS *
A
B
Figure 8 Sequences of EMSA probes used in this study. Sequences of p28-Omp14 P1-P5 (panel A) and p28-Omp19 P6 and P7 (panel B)
represent promoter segments utilized in the EMSA experiments.
A B
P7 P1 P2 P3
P1 P2 P3 P7
Probe DNA (1 ng) ++ + + ProbeDNA (1ng) Probe DNA (1 ng) + ++ + + +++ ++ ++ Probe DNA (1 ng) ++++
Competitor (50  ng)  ͲͲ +Ͳ
MQ-EhrP (5μg) Ͳ ++Ͳ
BSA            (5μg) ͲͲͲ+
ProbeDNA (1ng)
Competitor (50  ng) ͲͲ +Ͳ Ͳ Ͳ +Ͳ Ͳ Ͳ +Ͳ
MQ-EhrP (5μg) Ͳ ++Ͳ Ͳ ++Ͳ Ͳ ++Ͳ
BSA            (5μg)  ͲͲ Ͳ +Ͳ Ͳ Ͳ +Ͳ Ͳ Ͳ +
Probe DNA (1 ng) +      +     +    +          +    +     +     +           +     +      +     +            
Figure 9 EMSA using short segments of three biotin-labeled probes of p28-Omp14 (panel A) and one p28-Omp19 (panel B) promoter
segments. Addition of E. chaffeensis protein extracts (MQ-Ehr P) and unlabeled promoter DNA as a cold competitor (Competitor) or bovine
serum albumin (BSA) as a non-specific protein control are indicated in captions at the bottom of the Figure for both the panels.
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e n v i r o n m e n t s .T h i si st h ef i r s tr e p o r to fin vitro tran-
scription using native E. chaffeensis RNAP and E. coli
RNAP core enzyme reconstituted with the recombinant
E. chaffeensis s
70 subunit. This study marks the begin-
ning of a greater effort to broadly characterize the
mechanisms that controlt h et r a n s c r i p t i o ni nAnaplas-
mataceae pathogens in support of their growth in verte-
brate and tick hosts.
Methods
PCR conditions
PCRs for amplification of E. chaffeensis p28-Omp14 and
p28-Omp19 promoters were carried out in a 25 μl reac-
tion volume containing 0.2 μM of each primer, 250 ng
of purified E. chaffeensis (Arkansas isolate) genomic
DNA, 400 μM of each of the four deoxyribonucleoside
triphosphates, 1.5 mM MgSO4,1 xn a t i v eH i F iP C Rb u f -
fer (60 mM Tris-SO4,1 8m M( N H 4)2SO4), 2.5 units
HiFi polymerase. After the first denaturation step of
DNA at 95°C for 2 min, amplification was carried out
for 45 cycles of denaturation at 95°C for 30 s, annealing
at 40°C for 30 s and extension at 72°C for 50 s and a
final extension at 72°C for 2 min.
Construction of transcription plasmids
The plasmid pMT504 is a G-less cassette plasmid con-
taining two transcription templates cloned in opposite
directions to aid in driving transcription from promoters
introduced upstream of the G-less cassette sequences
[26]. We constructed in vitro transcription templates,
pRG147 and pRG198, by cloning the promoter regions
of p28-Omp14 and p28-Omp19, respectively, into the
pMT504 plasmid at EcoRV site (Figure 1). The promo-
ter sequences selected for preparing these constructs
included the sequences starting from the downstream
first nucleotide of the termination codon of the
upstream gene and up to the transcription start sites of
the genes mapped in our previous study [25]. Plasmid
pRG147 contained a 553 bp promoter region of p28-
Omp14 amplified from genomic DNA using primers
RRG217 and RRG695 (Table 1). Similarly, plasmid
pRG198 contained a 306 bp promoter region of p28-
Omp19 amplified by primers RRG185 and RRG696. All
oligonucleotide primers used in this study were designed
from the genome sequence data [24] and were synthe-
sized at Integrated DNA Technologies, Inc. (Coralville,
Iowa). Reverse primers for promoter segments included
the transcription start sites of the respective promoters
but excluding any guanosine residue downstream of the
transcription initiation sites. This is to avoid transcrip-
tion termination caused by incorporation methylated
g u a n o s i n et r i p h o s p h a t ep r e s e n ti nt h et r a n s c r i p t i o n
reactions (outlined below under in vitro transcription).
The promoter inserts were also cloned in opposite
orientation (pRG147R and pRG198R) to serve as nega-
tive controls to demonstrate promoter-specific in vitro
transcription.
Transcription from pRG147, pRG198 or pMT504
plasmids results in a shorter 125-nucleotide transcripts
encoded by a control transcription template positioned
downstream of the Chlamydia trachomatis rRNA P1
promoter. The test transcription template contains a
153-nucleotide G-less cassette segments in the opposite
direction to the control transcription template. This syn-
thetic template results in the transcription of a 162-
nucleotide transcript from the transcription start site for
both the p28-Omp14 and 19 gene promoters. Super-
coiled plasmids for use in the in vitro transcription
assays were prepared using the QIAprep Spin Miniprep
kit (Qiagen Inc., Valencia, CA) according to the manu-
facturer’s instructions. The DNA sequences of the pro-
moter templates were verified by restriction enzyme and
sequencing analysis.
In vitro transcription assays
In vitro transcription reactions were performed in a 10
μl final reaction volume with the following components;
50 mM Tris-acetate buffer pH 8.0 containing 50 mM
potassium acetate, 8.1 mM magnesium acetate, 27 mM
ammonium acetate, 80 mM NaCl, 2 mM DTT, 400 μM
ATP, 400 μMU T P ,2 . 1μM[ a-
32P]-CTP (800 Ci mmol
-
1 for radioisotope detection method) or 400 μMC T P
(for detection and quantification by real-time reverse
transcription PCR), 100 μM sodium salt of 3’-O-methyl-
guanosine 5’-triphosphate, 18 units of RNasin, 5% gly-
cerol, 0.13 pmol of supercoiled DNA template and 1 μl
(360 ng) of heparin-agarose purified E. chaffeensis
RNAP or 0.5 μlo f1 : 1 0d i l u t i o no fE. coli core enzyme
(Epicenter, Madison, WI) or 0.5 μl of 1:10 dilution of E.
coli s
70-saturated holoenzyme (Epicenter, Madison, WI).
For enzyme salt tolerance assays, potassium acetate and
NaCl concentrations were varied over a range from 0 to
600 mM and 0 to 120 mM, respectively. In transcription
reactions using E. chaffeensis recombinant s
70,R N A P
holoenzyme was reconstituted by adding 360 ng of
recombinant protein to 0.5 μl of 1:10 diluted E. coli core
enzyme. Holoenzyme formation was allowed to occur by
incubating the mixture on ice for 20 min. To assess the
modulatory effect on transcription, 4.0 μgo fE. chaffeen-
sis protein lysate (preparation described below) was
incubated for 20 min at room temperature with the
transcription reaction mixture in the absence of an
RNAP to allow binding of proteins to DNA elements of
promoter segments. Next, 1 μlo ft h ep u r i f i e dE. chaf-
feensis RNAP was added to reaction mixture. In general,
transcription reactions were incubated at 37°C for vary-
ing times of 7.5 min, 15 min or 30 min and the
Faburay et al. BMC Microbiology 2011, 11:83
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tion (95% formamide, 20 mM EDTA, 0.05% bromophe-
nol blue and 0.05% xylene cyanol). Six microliters of the
sample was electrophoresed on a 6% polyacrylamide
sequencing gel containing 7 M urea. The gels were
dried and transcripts were visualized by exposing an X-
ray film to the gels. Autoradiographs were scanned on a
HP SCANJET 5550 scanner (Hewlett-Packard
®).
Isolation of E. chaffeensis RNAP
The RNAP isolation method was a modified version
from the heparin-agarose procedure described in
[21,27,55]. E. chaffeensis Arkansas isolate was grown in
confluent DH82 cells (malignant canine monocyte/
macrophage cells) in 300 cm
2 culture flasks in 1 litre
MEM tissue culture medium containing 7% fetal bovine
serum (Gibco BRL
®) and 1.2 mM L-glutamine [56].
DH82 cultures infected with E. chaffeensis having predo-
minantly reticulate bodies (RB) were harvested 48 h
post-infection by centrifugation at 1,000 × g for 10 min
at 4°C in an Eppendorf 5810R centrifuge. (All centrifu-
gation steps were performed using this centrifuge.) The
purification steps were all performed at 4°C. The pellet
was resuspended in 25 ml sucrose potassium glutamate
(SPG) buffer (218 mM sucrose, 3.76 mM KH2PO4,7 . 1
mM K2HPO4, 5 mM potassium glutamate, pH 7.0) and
host cells were lysed in a 40 ml Wheaton homogenizer
with pestle A. The lysate was centrifuged at 800 × g for
10 min in 50 ml conical tubes to pellet host cell debris.
Subsequent supernatant was centrifuged at 15,000 × g
for 10 min to pellet the organisms. The RB pellet was
resuspended in 2 ml of freshly prepared lysis buffer [10
mM Tris-HCl (pH 8.0), 10 mM MgCl2,1 mM EDTA,
0.3 mM dithiothreitol (DTT), 7.5% glycerol (vol/vol), 50
mM NaCl, 1x Amersham protease inhibitor mixture,
and 150 μg per ml of lysozyme]. Lysis was facilitated by
three passages through 27.5 G needle. Sodium deoxy-
cholate (at final concentration of 0.05%) was added to
the lysate and the suspension incubated for 30 min at 4°
C. The lysate was centrifuged at 10,000 × g for 10 min
and the supernatant was collected and clarified by an
additional centrifugation step for 5 min.
The clarified supernatant was loaded onto pre-packed
heparin-agarose column (type I-S, Sigma
®)p r e v i o u s l y
equilibrated with buffer A [10 mM Tris HCl (pH 8.0),10
mM MgCl2,1 mM EDTA, 0.3 mM DTT, 7.5% glycerol
and 50 mM NaCl]. The suspension was adsorbed for 60
min at 4°C and the column was washed by gravity with
20 ml of buffer A for complete removal of unbound
proteins. The bound proteins from the column were
eluted by gravity with buffer A containing 0.6 M NaCl
and 0.5 ml fractions were collected. Based on previous
analysis and calculation of the void volume of the col-
umn, fractions 3-6 were pooled and dialyzed overnight
against storage buffer [10 mM Tris-HCl (pH 8.0), 10
mM MgCl2, 0.1 mM EDTA, 0.1 mM DTT, 50% glycerol
and 100 mM NaCl] using Slide-A-Lyzer Gamma Irra-
diated Dialysis Cassette (Thermo Scientific, Illinois,
USA). The fractions were stored at -80°C. RNAP activity
of the dialyzed fraction was determined by in vitro tran-
scription assay.
Protein concentration
Protein concentration of the HA purified RNAP frac-
tions and E. chaffeensis whole-protein lysates were mea-
sured with the bicinchoninic acid protein assay reagent
(Thermo Scientific, Illinois, USA) with bovine serum
albumin as the protein standard.
SDS-PAGE
Proteins were analyzed by electrophoresis in 7.5%
sodium dodecyl sulphate-polyacrylamide gel (SDS-
PAGE), followed by silver staining according to the pro-
cedures provided by the manufacturer (G Biosciences,
USA) or resolved proteins were transferred onto a nitro-
cellulose membrane, Hybond-ECL (Amersham Bios-
ciences, Germany), for immunoblot analysis.
Western blot (immunoblot) of RNAP extracts
E. chaffeensis RNAP purified above was subjected to
SDS-PAGE and the proteins were electroblotted for 2 h
at 70 V to a sheet of nitrocellulose membrane. The
membrane blot was blocked in a solution containing
10% nonfat dried milk (NFDM) freshly made in TTBS
[0.1% Tween-20 in 100 mM Tris-HCl (pH 7.5) and 0.9%
NaCl] for 1 h at room temperature with gentle agitation.
The blot was rinsed three times in TTBS and then was
incubated for 1 h at room temperature or overnight at
4°C with anti-E. coli s
70 antibody, 2G10 (Santa Cruz
Biotechnology Inc., Santa Cruz, CA), diluted 1: 500 in
1% NFDM in TTBS solution. The blot was washed
again three times with washing solution and then incu-
bated for 1 h at room temperature with horseradish per-
oxidase-conjugated anti-mouse immunoglobulin G
diluted 1:5000 in 1% NFDM in TTBS solution. The blot
was rinsed again three more times with TTBS to remove
excess secondary antibody and detection was carried out
using chemiluminescent detection reagents (Amersham
ECL™, GE Healthcare).
Properties of isolated E. chaffeensis RNAP
Assays to determine the salt tolerance of the purified
enzyme have been described above. Rifampin/rifampicin
is a potent inhibitor of prokaryotic RNAPs, but not for
eukaryotic RNAP [27]. As E. chaffeensis RNAP was
recovered from organisms grown in eukaryotic cells
(DH82), it may be potentially contaminated with eukar-
yotic RNAP. To confirm that the transcript formation is
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RNAP, in vitro transcription assays were performed in
the presence of rifampin at a concentration of 25 μgm l
-
1.
Functional studies with an E. coli RNAP monoclonal
antibody (2G10) demonstrated that it can effectively
bind to E. coli s
70 and markedly inhibit in vitro tran-
scriptional activity by RNAPs of E. coli [29] and C. tra-
chomatis [28]. To further assess that in vitro
transcriptional activity was due to E. chaffeensis purified
RNAP but not from eukaryotic RNAP, we utilized the E.
coli monoclonal antibody 2G10 in inhibition assays
assuming that it blocks the E. chaffeensis RNAP similar
to C. trachomatis RNAP. For this experiment, 4 μgo f
2G10-antibody was added in transcription reactions and
the production of transcripts were assessed by following
the methods described above.
Overexpression and purification of E. chaffeensis RpoD
(s
70)
T h ee n t i r eR p o D( s70 subunit gene) protein coding
sequence, identified from the E. chaffeensis Arkansas
isolate genome [24], was amplified by PCR and cloned
into the pET32 plasmid (Novagen, Madison, WI) for
producing recombinant protein. The PCR was per-
formed using pfu DNA polymerase (Promega, Madison,
WI) and with the gene-specific PCR primers, RRG742
and RRG 743 (Table 1). To facilitate directional cloning,
NcoIa n dXhoI restriction enzyme sites were engineered
in the PCR product. The PCR product was subsequently
cloned into pET32 plasmid at the above restriction sites
after digesting both plasmid and inserts and ligating
using T4 DNA ligase. Over expression of RpoD protein
and its purification was carried out with methods simi-
larly described elsewhere [20,57]. The concentration of
the purified RpoD protein was approximately 180 ng/μl,
as determined by protein estimation method (described
above).
Quantification of transcription
We carried out quantification of in vitro-generated RNA
transcripts of p28-Omp14 and p28-Omp19 promoters by
densitometry and TaqMan probe-based real-time RT-
PCR. For densitometric analysis, we quantitated the sig-
nal intensity of radio actively labelled transcripts on X-
ray films using ImageQuant software 5.2 (Molecular
Dynamics, Inc., Sunnyvale, CA). For real-time RT-PCR
analysis, primers and TaqMan probes for the 162 and
125 nucleotide (nt) G-less cassettes were designed
manually and optimized using Vector NTI Advance 11
software (Invitrogen, Carlsbad, CA). The primers and
probes used for these assays were listed in Table 1. The
TaqMan probe for the 162 nt cassette (RRG765) and
the probe for the 125 nt cassette (RRG768) have been
labelled with reporter fluorescent dyes TET and ROX
and quencher dyes Iowa Black FQ and Iowa Black RQ-
Sp, respectively. Real-time RT-PCR was carried out
using the SuperScript™ III One-Step RT-PCR reagents
(Invitrogen, Carlsbad, CA). Each RT-PCR reaction con-
tained the following: 1x reaction mix (containing 200
μMd N T P s ) ,5m MM g S O 4, 100 nM of each primer,
150 nM of each TaqMan probe, 1 μl of SuperScript III
reverse transcriptase/Platinum Taq mix and 1 μlo fin-
vitro transcribed RNA sample in a 25 μlv o l u m e .
Reverse transcription was carried out for 30 min at 48°C
followed by a denaturation step of 2 min at 95°C. The
PCR amplification was then performed for 40 cycles
with each cycle at 94°C for 15 s and 60°C for 30 s. All
reactions were carried out in triplicate using a Smart
Cycler system (Cepheid, Sunnyvale, CA). The threshold
cycle, Ct, values of the samples (containing 4.0 μgo fE.
chaffeensis protein lysate) were averaged from values
obtained from each reaction, and the promoter activity
was calculated as a relative level of expression to the
reference control in a separate tube. The relative level of
expression was calculated using the mathematical model
of relative expression ratio in real-time PCR under con-
stant reference gene expression [31]: Ratio = (Etarget)
ΔCT
target(control-sample),w h e r eE represents the PCR effi-
ciency of one cycle in the exponential phase and was
calculated according to the equation: E =1 0
[-1/slope].
Preparation of E. chaffeensis whole-cell soluble protein
lysates
E. chaffeensis organisms were cultivated in vitro in
canine macrophage (DH82) cell lines at 37°C or in ISE6
tick cells as described previously [18,56]. The protocols
for E. chaffeensis cell lysate preparations were similar to
previously described methods for E. chaffeensis, A. pha-
gocytophilum and other Gram negative bacterial organ-
isms [49,52,58]. Twenty five ml of about 80-100% E.
chaffeensis infected cultures were harvested using glass
beads. The cultures were centrifuged at 15,560 × g for
15 min to recover infected host cells and cell free E.
chaffeensis organisms. To release the organisms from
host cells, the pellet was resuspended in 10 ml SPK buf-
fer (0.5 K2HPO4, 0.5 M KH2PO4, and 0.38 M sucrose)
and sonicated twice for 30 sec at a setting of 6.5 in a
Sonic Dismembrator (Fisher Scientific, Pittsburgh, PA).
The cell lysates were centrifuged at 400 × g for 5 min
and the supernatant containing cell free E. chaffeensis
was filtered through a 5 μma n d3μm sterile isopore
membrane filters (Millipore, Billerica, MA). The filtrate
containing cell free organisms was centrifuged at 15,560
× g for 15 min at 4°C. The pellet containing E. chaffeen-
sis organisms was washed twice with 1.5 ml of lysis buf-
fer (150 mM Tris-HCl pH 8.0, 100 mM KCl, 10 mM
Magnesium Acetate, 1 mM EDTA, 2 mM DTT and 10%
Faburay et al. BMC Microbiology 2011, 11:83
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Page 13 of 15glycerol) and the pellet was resuspended in 1 ml of lysis
buffer containing protease inhibitors (Roche Diagnostic
Labs, Indianapolis, IN). The cell suspension was soni-
cated four times at 8.5 setting, 30 sec each time to lyse
E. chaffeensis organisms. The cell lysates were centri-
fuged at 15,560 × g for 15 min at 4°C to pellet the inso-
luble fraction and the supernatant containing soluble
proteins of E. chaffeensis was collected into sterile micro
c e n t r i f u g et u b e sa s2 5μl aliquots containing protease
inhibitor mix and stored at -80°C until use. Protein con-
centration of the protein lysates, prior to adding the
protease inhibitor mix, was estimated as described
above.
Electrophoretic mobility shift assay (EMSA)
DNA sequence segments spanning one or more putative
regulatory sequences of p28-Omp14 or p28-Omp19 gene
promoters were amplified from E. chaffeensis Arkansas
isolate genomic DNA using sequence specific primers
and 5’end biotin-labeled reverse primers (Table 1) and
evaluated for their interaction with the protein lysates.
EMSA experiments and detection were carried out
according to established protocols [57,58] with a radio-
active nucleotide incorporated DNA probes or using the
LightShift Chemiluminescent EMSA kit (Pierce Biotech-
nology, Rockford, Illinois, USA) according to the specifi-
cations of the manufacturer. The assay mixtures
included a non-specific DNA (salmon sperm DNA or
poly dI.dC at a high concentration of 240 μg/ml or 50
μg/ml, respectively) to eliminate non-specific interac-
tions. Briefly, about 1 ng of each of the full length or
biotin-labeled partial upstream sequences was used in
each reaction together with 5 μgo ft h eE. chaffeensis
whole-cell protein lysate. About 50 ng of unlabeled spe-
cific probe sequences were used as competitors. Bovine
serum albumin (BSA) was included in each experiment
a san o n - s p e c i f i cp r o t e i nc o n t r o l .T h ep r o t e i nc o n c e n -
tration in E. chaffeensis protein lysates used in these
experiments was similar to the work reported earlier
[41,49,58].
Statistical analysis
We carried out two-tailed t-tests with equal variances
for densitometry analysis and unequal variances for the
real-time RT-PCR analysis to comparatively analyse the
effect of addition of E. chaffeensis whole cell protein
lysate on transcription of p28-Omp14 (pRG147) and
p28-Omp19 (pRG198) promoters.
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